Bed Bath & Beyond Back to Mixed Earnings Trouble

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Bed Bath & Beyond Inc. (NASDAQ: BBBY) reported its third-quarter earnings Thursday after the market close as $1.23 in earnings per share and $2.94 billion in revenue, against Thomson Reuters consensus estimates of $1.19 in earnings per share and $2.97 billion in revenue. The third quarter from the previous year had $1.12 in earnings per share and $2.86 billion in revenue.

The company gave guidance for the fourth quarter in the range of $1.78 to $1.83 in earnings per share. Thomson Reuters has the consensus estimate at $1.80 in earnings per share.

In the second quarter Bed Bath & Beyond bought back approximately $1 billion in stock, which was nearly four times the size of the first quarter’s $273 million in share repurchases. The $1.1 billion accelerated share repurchase program, which commenced in July 2014, was completed in December 2014.  As of November 29, 2014, the remaining balance of the $2.0 billion share repurchase program was approximately $1.8 billion.

The company had over $1 billion in cash and cash equivalents at the end of the third quarter. This was versus $367 million at the beginning of the period. Retailers sure love that holiday-backed quarter.

24/7 Wall St. included a few recent key analyst calls for Bed Bath & Beyond:

  • Barclays maintained an Overweight rating and raised its price target to $87 from $70 on January 6
  • Citigroup reiterated a Hold rating and raised its price target to $80 from $70 on January 5
  • Canaccord Genuity upgraded Bed Bath & Beyond to a Buy rating from Hold and raised its price target to $91 from $66 on January 2

Shares of Bed Bath & Beyond closed Thursday up 1.6% at $79.45. Following the earnings report, the initial response in the post market was negative and shares were down over 5% at $75.15.

The company’s stock has a consensus analyst price target of $67.90 and a 52-week trading range of $54.96 to $79.62. It has a market cap of $14 billion.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618